These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 15081461)

  • 21. Delayed occurrence of complete heart block without warning after alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
    Kern MJ; Holmes DG; Simpson C; Bitar SR; Rajjoub H
    Catheter Cardiovasc Interv; 2002 Aug; 56(4):503-7. PubMed ID: 12124962
    [No Abstract]   [Full Text] [Related]  

  • 22. Pericardium-covered stent for septal myocardial ablation in hypertrophic obstructive cardiomyopathy.
    Gaspar J; Martínez-Ríos MA; Vonderwalde C; Rosas M; Ban-Hayashi E; Eidt-Lidt G; Kuri J
    Catheter Cardiovasc Interv; 1999 May; 47(1):73-9. PubMed ID: 10385166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Catheter treatment of hypertrophic obstructive cardiomyopathy].
    Gleichmann U; Seggewiss H; Faber L; Fassbender D; Schmidt HK; Strick S
    Dtsch Med Wochenschr; 1996 May; 121(21):679-85. PubMed ID: 8646974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delayed electrocardiographic changes after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy.
    Guo H; Wang P; Xing Y; Peng F; Jiang J; Yang B; You B; Qiu Y; Lee JD
    J Electrocardiol; 2007 Oct; 40(4):356.e1-6. PubMed ID: 17316677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transradial approach and subclavian wired temporary pacemaker to increase safety of alcohol septal ablation for treatment of obstructive hypertrophic cardiomyopathy: the TRASA trial.
    Cuisset T; Franceschi F; Prevot S; Ansaldi S; Habib G; Pankert M; Fourcade L; Poyet R; Bonnet JL; Quilici J
    Arch Cardiovasc Dis; 2011 Aug; 104(8-9):444-9. PubMed ID: 21944146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endocardial radiofrequency ablation of septal hypertrophy. A new catheter-based modality of gradient reduction in hypertrophic obstructive cardiomyopathy.
    Lawrenz T; Kuhn H
    Z Kardiol; 2004 Jun; 93(6):493-9. PubMed ID: 15252744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute predictors of subacute complete heart block after alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Chen AA; Palacios IF; Mela T; Yoerger DM; Picard MH; Vlahakes G; Lowry PA; Fifer MA
    Am J Cardiol; 2006 Jan; 97(2):264-9. PubMed ID: 16442376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The induction of a septal infarct as a therapeutic alternative in hypertrophic obstructive cardiomyopathy: new observations apropos a case].
    de la Torre Hernández JM; Sánchez Mata N; Riesco Riesco F; Ruiz Delgado B; Ochoteco Azcárate A; Zueco Gil J; Colman Dejean T
    Rev Esp Cardiol; 1999 May; 52(5):339-42. PubMed ID: 10368585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pacemaker therapy in a pediatric patient with hypertrophic obstructive cardiomyopathy and rapid intrinsic atrioventricular conduction.
    Mann C; Antretter H; Hammerer I
    Pediatr Cardiol; 1999; 20(3):229-31. PubMed ID: 10089254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complete heart block complicating alcohol septal ablation for hypertrophic cardiomyopathy.
    Cheng TO
    Tex Heart Inst J; 1999; 26(1):100. PubMed ID: 10217478
    [No Abstract]   [Full Text] [Related]  

  • 31. Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Noseworthy PA; Rosenberg MA; Fifer MA; Palacios IF; Lowry PA; Ruskin JN; Sanborn DM; Picard MH; Vlahakes GJ; Mela T; Das S
    Am J Cardiol; 2009 Jul; 104(1):128-32. PubMed ID: 19576333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical features of five patients with delayed third degree atrioventricular block after ethanol septal ablation for hypertrophic obstructive cardiomyopathy].
    Liu R; Qiao SB; Hu FH; Yang WX; Yuan JS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Dec; 40(12):1009-11. PubMed ID: 23363714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac electromechanical mapping in analyzing the mechanism of left ventricular remodeling immediately after percutaneous transluminal septal ablation in patients with hypertrophic obstructive cardiomyopathy.
    Chen SL; Huang J; Ye F; Shan SJ; Zhang JJ; Duan BX; Chen YD
    Chin Med J (Engl); 2005 Nov; 118(21):1779-85. PubMed ID: 16336814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Sorajja P; Valeti U; Nishimura RA; Ommen SR; Rihal CS; Gersh BJ; Hodge DO; Schaff HV; Holmes DR
    Circulation; 2008 Jul; 118(2):131-9. PubMed ID: 18591440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcatheter alcohol ablation of the septum in a patient of hypertrophic obstructive cardiomyopathy.
    Bhargava B; Agarwal R; Kaul U; Manchanda SC; Wasir HS
    Cathet Cardiovasc Diagn; 1997 May; 41(1):56-8. PubMed ID: 9143769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of complete heart block after alcohol septal ablation for hypertrophic cardiomyopathy and the timing of pacemaker implantation.
    El-Jack SS; Nasif M; Blake JW; Dixon SR; Grines CL; O'Neill WW
    J Interv Cardiol; 2007 Feb; 20(1):73-6. PubMed ID: 17300408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of myocardial contrast echocardiographic quantification of risk area for predicting postprocedural complications in patients undergoing septal ethanol ablation for obstructive hypertrophic cardiomyopathy.
    Monakier D; Woo A; Puri T; Schwartz L; Ross J; Jamorski M; Yang H; Liu Z; Vannan M; Wigle ED; Rakowski H
    Am J Cardiol; 2004 Dec; 94(12):1515-22. PubMed ID: 15589007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delayed occurrence of complete heart block after ethanol septal ablation for hypertrophic obstructive cardiomyopathy.
    Poyet R; Quilici J; Cuisset T; Bali L; Ansaldi S; Prévost S; Habib G; Bonnet JL
    Int J Cardiol; 2011 Mar; 147(2):e32-4. PubMed ID: 19232758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome of surgical myectomy after unsuccessful alcohol septal ablation for the treatment of patients with hypertrophic obstructive cardiomyopathy.
    Nagueh SF; Buergler JM; Quinones MA; Spencer WH; Lawrie GM
    J Am Coll Cardiol; 2007 Aug; 50(8):795-8. PubMed ID: 17707185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of percutaneous intervention for patients with obstructive hypertrophic cardiomyopathy and coronary artery disease.
    Nambi V; Buergler JM; Lakkis NM; Franklin J; Spencer WH; Nagueh SF
    Am J Cardiol; 2005 Aug; 96(4):580-1. PubMed ID: 16098315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.